We can’t show the full text here under this license. Use the link below to read it at the source.
Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, Aβ phagocytosis, neuronal damage, and cell survival in Alzheimer’s disease
Microglial TLR4-Lyn kinase controls brain inflammation, amyloid removal, nerve cell damage, and survival in Alzheimer's disease
AI simplified
Abstract
An increased direct protein-protein interaction between and was observed in the brains of 5XFAD mice compared to wild-type mice.
- The interaction between TLR4 and Lyn kinase may influence inflammatory and phagocytosis signaling pathways in Alzheimer's disease.
- In the absence of Lyn, 5XFAD x Lyn mice showed increased expression of protective Syk kinase and enhanced Aβ phagocytosis.
- Increased astrocyte activity and decreased neuronal dystrophy were noted in 5XFAD x Lyn mice.
- in 5XFAD mice exhibited higher levels of TLR4 and Lyn, along with greater inflammatory cytokine production.
- In vitro treatment with TLR4-Lyn Interaction Modulators (TLIMs) resulted in increased Aβ phagocytosis and decreased neuronal dystrophy.
AI simplified
Key numbers
1.5×
Increase in Population
Comparing populations in Lyn-deficient vs. control 5XFAD mice.
17.9 nM
TLIM IC50 Concentration
Determined through dose-response curve for TLIM treatment.